Drug Type Small molecule drug |
Synonyms BMS-890068 |
Target |
Mechanism NS3 inhibitors(Hepatitis C virus (HCV) nonstructural protein 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC37H45ClF3N5O9S |
InChIKeyWMIBFNQEWGQYLI-YNWIYCBDSA-N |
CAS Registry1988754-04-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis C | Preclinical | US | 26 Aug 2016 | |
Hepatitis C | Preclinical | IN | 26 Aug 2016 |